Extraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea
dc.contributor.author | Uz, U | |
dc.contributor.author | Guenhan, K | |
dc.contributor.author | Pabuscu, Y | |
dc.contributor.author | Mutlu, S | |
dc.contributor.author | Kamiloglu, U | |
dc.date.accessioned | 2025-04-10T10:27:06Z | |
dc.date.available | 2025-04-10T10:27:06Z | |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) is a highly contagious disease that has reached pandemic status. The diagnosis of COVID-19 is made using the polymerase chain reaction test to evaluate a swab taken from the naso/oro-pharyngeal area. Since COVID-19 is still a pandemic, it is thought that the use of this diagnostic test will be on the agenda for a while. A patient with COVID-19 symptoms presented with unilateral cerebrospinal fluid rhinorrhea after a nasopharyngeal swab test. Although nasopharyngeal swabs are taken very frequently, the complication rate is very low. However, life-threatening complications can be observed on rare occasions, and care should be taken. | |
dc.identifier.e-issn | 1536-3732 | |
dc.identifier.issn | 1049-2275 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/34669 | |
dc.language.iso | English | |
dc.title | Extraordinary Complication of COVID-19 Swab Testing: CSF Rhinorrhea | |
dc.type | Article |